<!DOCTYPE html><html lang="Zh-CN" data-theme="light"><head><meta charset="UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1.0,viewport-fit=cover"><title>生理药理学第十五章 | 夜雕の博客</title><meta name="author" content="夜雕"><meta name="copyright" content="夜雕"><meta name="format-detection" content="telephone=no"><meta name="theme-color" content="#ffffff"><meta name="description" content="第十五章 抗心律失常、抗动脉硬化药第一节 抗心律失常药一、膜电位的基本知识● 双层磷脂。● 高电阻，构成绝缘层，隔绝细胞内外。● 不通透离子和水溶性分子。● 细胞内外均为导电的盐溶液，构成膜电容。● 磷脂双层含有协助离子以及物质通过的蛋白，如离子通道和转运蛋白。● 膜电路。 1、静息电位 (Resting Potential, RP)未受刺激时膜内外电位差（稳态）。神经元静息电位在-30 ⁓ -9">
<meta property="og:type" content="article">
<meta property="og:title" content="生理药理学第十五章">
<meta property="og:url" content="https://blog.yediao.dpdns.org/2025/05/08/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/index.html">
<meta property="og:site_name" content="夜雕の博客">
<meta property="og:description" content="第十五章 抗心律失常、抗动脉硬化药第一节 抗心律失常药一、膜电位的基本知识● 双层磷脂。● 高电阻，构成绝缘层，隔绝细胞内外。● 不通透离子和水溶性分子。● 细胞内外均为导电的盐溶液，构成膜电容。● 磷脂双层含有协助离子以及物质通过的蛋白，如离子通道和转运蛋白。● 膜电路。 1、静息电位 (Resting Potential, RP)未受刺激时膜内外电位差（稳态）。神经元静息电位在-30 ⁓ -9">
<meta property="og:locale" content="zh_CN">
<meta property="og:image" content="https://blog.yediao.dpdns.org/img/s1.png">
<meta property="article:published_time" content="2025-05-08T06:13:16.000Z">
<meta property="article:modified_time" content="2025-05-12T09:25:43.166Z">
<meta property="article:author" content="夜雕">
<meta property="article:tag" content="学习笔记">
<meta property="article:tag" content="生物制药">
<meta property="article:tag" content="生理药理学">
<meta name="twitter:card" content="summary">
<meta name="twitter:image" content="https://blog.yediao.dpdns.org/img/s1.png"><script type="application/ld+json">{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "生理药理学第十五章",
  "url": "https://blog.yediao.dpdns.org/2025/05/08/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/",
  "image": "https://blog.yediao.dpdns.org/img/s1.png",
  "datePublished": "2025-05-08T06:13:16.000Z",
  "dateModified": "2025-05-12T09:25:43.166Z",
  "author": [
    {
      "@type": "Person",
      "name": "夜雕",
      "url": "https://blog.yediao.dpdns.org/"
    }
  ]
}</script><link rel="shortcut icon" href="/img/tennouji.ico"><link rel="canonical" href="https://blog.yediao.dpdns.org/2025/05/08/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/index.html"><link rel="preconnect" href="//cdn.jsdelivr.net"/><link rel="preconnect" href="//static.cloudflareinsights.com"/><link rel="preconnect" href="//busuanzi.ibruce.info"/><link rel="stylesheet" href="/css/index.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free/css/all.min.css"><script>
    (() => {
      
    const saveToLocal = {
      set: (key, value, ttl) => {
        if (!ttl) return
        const expiry = Date.now() + ttl * 86400000
        localStorage.setItem(key, JSON.stringify({ value, expiry }))
      },
      get: key => {
        const itemStr = localStorage.getItem(key)
        if (!itemStr) return undefined
        const { value, expiry } = JSON.parse(itemStr)
        if (Date.now() > expiry) {
          localStorage.removeItem(key)
          return undefined
        }
        return value
      }
    }

    window.btf = {
      saveToLocal,
      getScript: (url, attr = {}) => new Promise((resolve, reject) => {
        const script = document.createElement('script')
        script.src = url
        script.async = true
        Object.entries(attr).forEach(([key, val]) => script.setAttribute(key, val))
        script.onload = script.onreadystatechange = () => {
          if (!script.readyState || /loaded|complete/.test(script.readyState)) resolve()
        }
        script.onerror = reject
        document.head.appendChild(script)
      }),
      getCSS: (url, id) => new Promise((resolve, reject) => {
        const link = document.createElement('link')
        link.rel = 'stylesheet'
        link.href = url
        if (id) link.id = id
        link.onload = link.onreadystatechange = () => {
          if (!link.readyState || /loaded|complete/.test(link.readyState)) resolve()
        }
        link.onerror = reject
        document.head.appendChild(link)
      }),
      addGlobalFn: (key, fn, name = false, parent = window) => {
        if (!false && key.startsWith('pjax')) return
        const globalFn = parent.globalFn || {}
        globalFn[key] = globalFn[key] || {}
        globalFn[key][name || Object.keys(globalFn[key]).length] = fn
        parent.globalFn = globalFn
      }
    }
  
      
      const activateDarkMode = () => {
        document.documentElement.setAttribute('data-theme', 'dark')
        if (document.querySelector('meta[name="theme-color"]') !== null) {
          document.querySelector('meta[name="theme-color"]').setAttribute('content', '#0d0d0d')
        }
      }
      const activateLightMode = () => {
        document.documentElement.setAttribute('data-theme', 'light')
        if (document.querySelector('meta[name="theme-color"]') !== null) {
          document.querySelector('meta[name="theme-color"]').setAttribute('content', '#ffffff')
        }
      }

      btf.activateDarkMode = activateDarkMode
      btf.activateLightMode = activateLightMode

      const theme = saveToLocal.get('theme')
    
          theme === 'dark' ? activateDarkMode() : theme === 'light' ? activateLightMode() : null
        
      
      const asideStatus = saveToLocal.get('aside-status')
      if (asideStatus !== undefined) {
        document.documentElement.classList.toggle('hide-aside', asideStatus === 'hide')
      }
    
      
    const detectApple = () => {
      if (/iPad|iPhone|iPod|Macintosh/.test(navigator.userAgent)) {
        document.documentElement.classList.add('apple')
      }
    }
    detectApple()
  
    })()
  </script><script defer="defer" data-pjax="data-pjax" src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon="{&quot;token&quot;: &quot;e6846ba78c4943cdaff5d550767755b5&quot;}"></script><script>const GLOBAL_CONFIG = {
  root: '/',
  algolia: undefined,
  localSearch: {"path":"/search.xml","preload":false,"top_n_per_article":1,"unescape":false,"languages":{"hits_empty":"No results found for: ${query}","hits_stats":"${hits} articles found"}},
  translate: undefined,
  highlight: {"plugin":"highlight.js","highlightCopy":true,"highlightLang":true,"highlightHeightLimit":200,"highlightFullpage":false,"highlightMacStyle":false},
  copy: {
    success: 'Copy Successful',
    error: 'Copy Failed',
    noSupport: 'Browser Not Supported'
  },
  relativeDate: {
    homepage: false,
    post: false
  },
  runtime: '',
  dateSuffix: {
    just: 'Just now',
    min: 'minutes ago',
    hour: 'hours ago',
    day: 'days ago',
    month: 'months ago'
  },
  copyright: undefined,
  lightbox: 'null',
  Snackbar: undefined,
  infinitegrid: {
    js: 'https://cdn.jsdelivr.net/npm/@egjs/infinitegrid/dist/infinitegrid.min.js',
    buttonText: 'Load More'
  },
  isPhotoFigcaption: false,
  islazyloadPlugin: false,
  isAnchor: false,
  percent: {
    toc: true,
    rightside: false,
  },
  autoDarkmode: false
}</script><script id="config-diff">var GLOBAL_CONFIG_SITE = {
  title: '生理药理学第十五章',
  isHighlightShrink: false,
  isToc: true,
  pageType: 'post'
}</script><link rel="stylesheet" href="/css/wave.css?1"><link rel="stylesheet" href="/css/font.css"><link rel="stylesheet" href="/css/fa-shake.css"><link rel="stylesheet" href="/css/heimu.css"><link rel="stylesheet" href="/css/currency.css"><meta name="generator" content="Hexo 7.3.0"></head><body><div id="web_bg" style="background-image: url(/img/背景.jpg);"></div><div id="sidebar"><div id="menu-mask"></div><div id="sidebar-menus"><div class="avatar-img text-center"><img src="/img/%E8%99%B9%E5%92%B2.ico" onerror="this.onerror=null;this.src='/img/404.jpg'" alt="avatar"/></div><div class="site-data text-center"><a href="/archives/"><div class="headline">Articles</div><div class="length-num">36</div></a><a href="/tags/"><div class="headline">Tags</div><div class="length-num">12</div></a><a href="/categories/"><div class="headline">Categories</div><div class="length-num">0</div></a></div><div class="menus_items"><div class="menus_item"><a class="site-page" href="/"><i class="fa-fw fas fa-home"></i><span> Home</span></a></div><div class="menus_item"><a class="site-page" href="/tags/"><i class="fa-fw fas fa-tags"></i><span> Tags</span></a></div><div class="menus_item"><a class="site-page" href="/categories/"><i class="fa-fw fas fa-folder-open"></i><span> Categories</span></a></div></div></div></div><div class="post" id="body-wrap"><header class="post-bg" id="page-header" style="background-image: url(/img/bg.jpg);"><nav id="nav"><span id="blog-info"><a class="nav-site-title" href="/"><img class="site-icon" src="/img/%E8%99%B9%E5%92%B2.ico" alt="Logo"><span class="site-name">夜雕の博客</span></a><a class="nav-page-title" href="/"><span class="site-name">生理药理学第十五章</span></a></span><div id="menus"><div id="search-button"><span class="site-page social-icon search"><i class="fas fa-search fa-fw"></i><span> Search</span></span></div><div class="menus_items"><div class="menus_item"><a class="site-page" href="/"><i class="fa-fw fas fa-home"></i><span> Home</span></a></div><div class="menus_item"><a class="site-page" href="/tags/"><i class="fa-fw fas fa-tags"></i><span> Tags</span></a></div><div class="menus_item"><a class="site-page" href="/categories/"><i class="fa-fw fas fa-folder-open"></i><span> Categories</span></a></div></div><div id="toggle-menu"><span class="site-page"><i class="fas fa-bars fa-fw"></i></span></div></div></nav><div id="post-info"><h1 class="post-title">生理药理学第十五章</h1><div id="post-meta"><div class="meta-firstline"><span class="post-meta-date"><i class="far fa-calendar-alt fa-fw post-meta-icon"></i><span class="post-meta-label">Created</span><time class="post-meta-date-created" datetime="2025-05-08T06:13:16.000Z" title="Created 2025-05-08 14:13:16">2025-05-08</time><span class="post-meta-separator">|</span><i class="fas fa-history fa-fw post-meta-icon"></i><span class="post-meta-label">Updated</span><time class="post-meta-date-updated" datetime="2025-05-12T09:25:43.166Z" title="Updated 2025-05-12 17:25:43">2025-05-12</time></span></div><div class="meta-secondline"><span class="post-meta-separator">|</span><span class="post-meta-wordcount"><i class="far fa-file-word fa-fw post-meta-icon"></i><span class="post-meta-label">Word Count:</span><span class="word-count">2.7k</span><span class="post-meta-separator">|</span><i class="far fa-clock fa-fw post-meta-icon"></i><span class="post-meta-label">Reading Time:</span><span>8mins</span></span><span class="post-meta-separator">|</span><span class="post-meta-pv-cv" id="" data-flag-title=""><i class="far fa-eye fa-fw post-meta-icon"></i><span class="post-meta-label">Post Views:</span><span id="busuanzi_value_page_pv"><i class="fa-solid fa-spinner fa-spin"></i></span></span></div></div></div><section class="main-hero-waves-area waves-area"><svg class="waves-svg" xmlns="http://www.w3.org/2000/svg" xlink="http://www.w3.org/1999/xlink" viewBox="0 24 150 28" preserveAspectRatio="none" shape-rendering="auto"><defs><path id="gentle-wave" d="M -160 44 c 30 0 58 -18 88 -18 s 58 18 88 18 s 58 -18 88 -18 s 58 18 88 18 v 44 h -352 Z"></path></defs><g class="parallax"><use href="#gentle-wave" x="48" y="0"></use><use href="#gentle-wave" x="48" y="3"></use><use href="#gentle-wave" x="48" y="5"></use><use href="#gentle-wave" x="48" y="7"></use></g></svg></section></header><main class="layout" id="content-inner"><div id="post"><article class="container post-content" id="article-container"><h1 id="第十五章-抗心律失常、抗动脉硬化药"><a href="#第十五章-抗心律失常、抗动脉硬化药" class="headerlink" title="第十五章 抗心律失常、抗动脉硬化药"></a><span style="display:block;text-align:center;color:#00BFFF;">第十五章 抗心律失常、抗动脉硬化药</span></h1><h2 id="第一节-抗心律失常药"><a href="#第一节-抗心律失常药" class="headerlink" title="第一节 抗心律失常药"></a>第一节 抗心律失常药</h2><h3 id="一、膜电位的基本知识"><a href="#一、膜电位的基本知识" class="headerlink" title="一、膜电位的基本知识"></a>一、膜电位的基本知识</h3><p>● 双层磷脂。<br>● 高电阻，构成绝缘层，隔绝细胞内外。<br>● 不通透离子和水溶性分子。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/1.png"><br>● 细胞内外均为导电的盐溶液，构成膜电容。<br>● 磷脂双层含有协助离子以及物质通过的蛋白，如离子通道和转运蛋白。<br>● 膜电路。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/2.png"></p>
<h4 id="1、静息电位-Resting-Potential-RP"><a href="#1、静息电位-Resting-Potential-RP" class="headerlink" title="1、静息电位 (Resting Potential, RP)"></a><font size="4"><span style="color:#D81C2F">1、静息电位 (Resting Potential, RP)</span></font></h4><p><span style="color:#D81C2F">未受刺激时膜内外电位差（稳态）。</span>神经元静息电位在-30 ⁓ -90 mV之间。<span style="color:#D81C2F">外正内负。</span><br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/3.png"><br><span style="color:#D81C2F"><br>极化状态 (polarization)<br>● 去极化 (Depolarization)，负值减少<br>● 复极化 (Repolarization)，恢复极化状态<br>● 超极化 (Hyperpolarization)，负值增加<br></span><br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/4.png"><br>静息电位的离子机制</p>
<p>● 细胞内外离子分布不平衡<br>● 离子的扩散 (K+&gt;Na+)<br>● 钠-钾交换泵的作用<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/5.png"><br>正常情况下，细胞内K+&gt;&gt;细胞外，而Na+浓度则相反。离子具有向低浓度方向扩散的趋势。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/6.png"></p>
<h4 id="2、动作电位-Action-Potential-AP"><a href="#2、动作电位-Action-Potential-AP" class="headerlink" title="2、动作电位 (Action Potential, AP)"></a><font size="4"><span style="color:#D81C2F">2、动作电位 (Action Potential, AP)</span></font></h4><p>静息电位，稳定态<br>局部电位，过渡态<br>动作电位，电信号传导</p>
<h5 id="（1）局部电位：由兴奋引起的电紧张电位。"><a href="#（1）局部电位：由兴奋引起的电紧张电位。" class="headerlink" title="（1）局部电位：由兴奋引起的电紧张电位。"></a><font size="4">（1）局部电位：由兴奋引起的电紧张电位。</font></h5><p>局部电位的离子机制</p>
<p>● 兴奋产生电紧张电位激活电压门控Na+通道。<br>● 少量Na+内流，引起部分去极化反应。<br>● Na+内流不足以克服K+外流的作用。<br>● Na+内流产生紧张电位成为局部电位。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/7.png"></p>
<h5 id="（2）动作电位-Action-Potential-AP"><a href="#（2）动作电位-Action-Potential-AP" class="headerlink" title="（2）动作电位 (Action Potential, AP)"></a><font size="4"><span style="color:#D81C2F">（2）动作电位 (Action Potential, AP)</span></font></h5><p><strong><span style="color:#D81C2F">细胞活动的标志，信息传导的基本单元。电信号分去极化和超极化。</span></strong><br><span style="color:#D81C2F">● 去极化：极化的减弱，代表兴奋性升高或激活。<br>● 超极化：极化的增强，代表兴奋性降低或抑制。<br></span><br>AP的过程：静息电位 (Resting Potential)<br>阀电位(Threshold Potential)<br>锋电位 (Spike Potential)<br>后电位 (After-spike Potential), 复极化后电位和超极化后电位<br>反极化或超射(Overshoot)<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/8.png"><br><span style="color:#D81C2F">动作电位的离子机制<br>● 刺激诱发电压门控Na+通道开放Na+内流克服K+外流。<br>● Na+内流，K+通道关闭。<br>● Na+通道失活与K+通道激活达到新的平衡（锋电位）。<br>● K+通道开启外流，Na+通道关闭。<br>● 锋电位上升一般Na+通道介导，但电压门控Ca2+通道也发挥重要作用。<br><br>后电位的离子机制<br>●大量K+外流导致细胞外K+积蓄，延缓复极化过程。<br>● Na+-K+泵协调电位回复。<br></span><br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/9.png"> </p>
<h3 id="二、心脏的电生理"><a href="#二、心脏的电生理" class="headerlink" title="二、心脏的电生理"></a>二、心脏的电生理</h3><p>根据电生理特性分类：<br><span style="color:#D81C2F">● 工作细胞(心房肌与心室肌，机械收缩作用)。<br>● 自律细胞(窦房结细胞与浦肯野细胞)。<br></span><br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/10.png"><br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/11.png"><br>跨膜电位以及形成机制<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/12.png"><br><span style="color:#D81C2F"><br>● 动作电位：5个阶段。0期为去极化，1-4为复极化。<br>1、快速复极初期<br>2、平台期<br>3、快速复极末期<br>4、恢复期<br></span><br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/13.png"></p>
<span style="display:block;text-align:center;">
<font size="4">
体表心电图(Electrocardiogram, ECG)
</font>
</span>
<table>
  <tr>
    <td height="50%"><img src="/../img/生理药理学/第十五章/14.png" ></td>
    <td height="50%"><img src="/../img/生理药理学/第十五章/15.png" ></td>
  </tr>
</table>

<p><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/16.png"><br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/17.png"><br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/18.png"></p>
<h3 id="三、心律失常的发生机制"><a href="#三、心律失常的发生机制" class="headerlink" title="三、心律失常的发生机制"></a>三、心律失常的发生机制</h3><p><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/19.png"></p>
<h4 id="1、自律性升高"><a href="#1、自律性升高" class="headerlink" title="1、自律性升高"></a><font size="4">1、自律性升高</font></h4><p><strong>本来有自律性的组织自律性升高。本来无自律性的组织产生自律性。</strong></p>
<h5 id="（1）自律性"><a href="#（1）自律性" class="headerlink" title="（1）自律性"></a><font size="4">（1）自律性</font></h5><p>● 心肌在无外来刺激下能自动产生节律性兴奋的能力。<br>● 仅小部分心脏细胞具有自律性，如窦房结的起搏细胞 (100次&#x2F;分钟)。<br>● 窦房结为心脏活动正常起搏点，自律性最高，依次传导至其它组织细胞。</p>
<h5 id="（2）影响自律性的因素"><a href="#（2）影响自律性的因素" class="headerlink" title="（2）影响自律性的因素"></a><font size="4">（2）影响自律性的因素</font></h5><p>● 4期去极化速度<br>● 最大复极电位<br>● 阀电位高低</p>
<h5 id="（3）自律性升高原因"><a href="#（3）自律性升高原因" class="headerlink" title="（3）自律性升高原因"></a><font size="4">（3）自律性升高原因</font></h5><p>● 电解质紊乱<br>● 心肌缺血缺氧</p>
<table>
  <tr>
    <td width="40%">
    <span>
<font size="4"><br>
A：速度由a到b时，自律性下降<br><br><br><br>
B：最大复极电位由a到d，或阀电位由TP-1升至TP-2时，自律性降低。
</font>
    </span>
    </td>
    <td width="60%">
    <img src="/../img/生理药理学/第十五章/20.png" >
    </td>
  </tr>
</table>

<h4 id="2、触发活动"><a href="#2、触发活动" class="headerlink" title="2、触发活动"></a><font size="4">2、触发活动</font></h4><p>（1）早后除极<br>（2）迟后除极<br>●频率快，振幅小<br>●震荡性波动，膜电位不稳定<br>（3）原因<br>● 低血钾 (早后除极)<br>● 强心苷中毒、胞外高钙及低钾(迟后除极)<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/21.png"></p>
<h4 id="3、冲动传导障碍-折返激动"><a href="#3、冲动传导障碍-折返激动" class="headerlink" title="3、冲动传导障碍 (折返激动)"></a><font size="4">3、冲动传导障碍 (折返激动)</font></h4><table>
  <tr>
    <td height="50%"><img src="/../img/生理药理学/第十五章/22.png" ></td>
    <td height="50%"><img src="/../img/生理药理学/第十五章/23.png" ></td>
  </tr>
</table>
● 钠通道抑制作用强的药物易诱发折返激动。

<h3 id="四、心律失常治疗策略"><a href="#四、心律失常治疗策略" class="headerlink" title="四、心律失常治疗策略"></a>四、心律失常治疗策略</h3><h4 id="1、非药物治疗"><a href="#1、非药物治疗" class="headerlink" title="1、非药物治疗"></a><font size="4">1、非药物治疗</font></h4><h5 id="（1）起搏器"><a href="#（1）起搏器" class="headerlink" title="（1）起搏器"></a><font size="4">（1）起搏器</font></h5><p>● 植入体内，发放电脉冲，刺激电极所接触的心肌，使心脏激动和收缩，从而治疗心律失常所致的心脏功能障碍。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/24.png"></p>
<h5 id="（2）导管消融和手术"><a href="#（2）导管消融和手术" class="headerlink" title="（2）导管消融和手术"></a><font size="4">（2）导管消融和手术</font></h5><p>● 电极导管插入心脏确定的引起心动过速的异常结构的位置，然后局部释放高频电流，在小的范围内产生很高的温度，通过热效能，使局部组织内水分蒸发，干燥坏死，达到治疗目的。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/25.png"></p>
<h5 id="（3）电复律-心脏电除颤"><a href="#（3）电复律-心脏电除颤" class="headerlink" title="（3）电复律(心脏电除颤)"></a><font size="4">（3）电复律(心脏电除颤)</font></h5><p>● 严重心律失常时，用短暂高压强电流通过心脏，使全部或大部分心肌细胞在瞬间同时除极，造成心脏短暂的电活动停止，然后重新主导心脏节律的治疗过程。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/26.png"></p>
<h4 id="2、药物治疗-双刃剑"><a href="#2、药物治疗-双刃剑" class="headerlink" title="2、药物治疗 (双刃剑)"></a><font size="4">2、药物治疗 (双刃剑)</font></h4><h5 id="（1）降低自律性"><a href="#（1）降低自律性" class="headerlink" title="（1）降低自律性"></a><font size="4">（1）降低自律性</font></h5><p>● 降低动作电位4相斜率<br>● 提高动作电位阈值(钠通道阻碍药)<br>● 延长动作电位时程 (钾通道阻碍药)<br>● 增加静息电位绝对值(钙通道阻碍药)</p>
<h5 id="（2）减少后除极"><a href="#（2）减少后除极" class="headerlink" title="（2）减少后除极"></a><font size="4">（2）减少后除极</font></h5><p>● 减少迟后除极( 钙通道阻碍药)<br>● 抑制迟后除极0相去极化(钠通道阻碍药)</p>
<h5 id="（3）消除折返"><a href="#（3）消除折返" class="headerlink" title="（3）消除折返"></a><font size="4">（3）消除折返</font></h5><p>● 改变传导(钙通道阻碍药和β受体阻断药)<br>● 延长有效不应期(钠、钾、钙通道阻碍药)</p>
<h3 id="五、常见抗心律失常药物"><a href="#五、常见抗心律失常药物" class="headerlink" title="五、常见抗心律失常药物"></a>五、常见抗心律失常药物</h3><h4 id="（一）钠通道阻滞药-I类"><a href="#（一）钠通道阻滞药-I类" class="headerlink" title="（一）钠通道阻滞药 (I类)"></a><font size="4">（一）钠通道阻滞药 (I类)</font></h4><p><strong>抑制钠通道，降低0相上升速率，膜稳定剂或快通道阻滞剂。</strong></p>
<p><strong>IA类，复活时间(τrecovery) 1-10s，适度阻滞钠通道。</strong></p>
<p>● 影响传导速度，延长电位时程。<br>● 奎尼丁、普鲁卡因胺。</p>
<p><strong>IB类，&lt;1s，轻度阻滞钠通道。</strong></p>
<p>● 减慢传导速度，动作电位缩短或不变。<br>● 利多卡因、苯妥英钠、美西律等。</p>
<p><strong>IC类，&gt;10s，显著阻滞钠通道。</strong></p>
<p>● 明显阻滞传导速度，延长动作电位。<br>● 普罗帕酮。</p>
<p><strong>适用于快速型心率失常、室性心动过速</strong></p>
<p><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/27.png"></p>
<h4 id="（二）β肾上腺素受体阻断药"><a href="#（二）β肾上腺素受体阻断药" class="headerlink" title="（二）β肾上腺素受体阻断药"></a><font size="4">（二）β肾上腺素受体阻断药</font></h4><p>●阻断β受体，同时具有阻滞钠通道和缩短复极过程作用。<br>●减慢4相除极速率而降低自律性，降低动作电位0相上升速率而减慢传导。<br>● 室上性心律失常、中枢性心律失常。</p>
<h4 id="（三）延长动作电位时程药"><a href="#（三）延长动作电位时程药" class="headerlink" title="（三）延长动作电位时程药"></a><font size="4">（三）延长动作电位时程药</font></h4><p>● 阻滞钾通道，减少钾离子外流。<br>● 延长动作电位时程，但对动作电位幅度和去极化速率影响较小。<br>● 室性心律失常、心房颤动、心动过速。</p>
<h4 id="（四）钙通道阻滞剂"><a href="#（四）钙通道阻滞剂" class="headerlink" title="（四）钙通道阻滞剂"></a><font size="4">（四）钙通道阻滞剂</font></h4><p>● 阻滞L-型钙通道，减少钙电流。<br>● 降低窦房结、房室细胞自律性，减慢房室传导速度，延长不应期。<br>● 室上性和房室折返心律失常</p>
<h3 id="六、抗心律失常用药原则"><a href="#六、抗心律失常用药原则" class="headerlink" title="六、抗心律失常用药原则"></a>六、抗心律失常用药原则</h3><p>1、先单独用药，后联合用药。</p>
<p>2、用有临床效果的最小剂量。</p>
<p>3、考虑危险性优先，</p>
<p>4、减少致心律失常等副作用。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/28.png"></p>
<h2 id="第二节-抗动脉硬化药"><a href="#第二节-抗动脉硬化药" class="headerlink" title="第二节 抗动脉硬化药"></a>第二节 抗动脉硬化药</h2><h3 id="一、血脂代谢生理学"><a href="#一、血脂代谢生理学" class="headerlink" title="一、血脂代谢生理学"></a>一、血脂代谢生理学</h3><span style="color:#D81C2F">
血脂<br>
● 甘油三酯(TG)<br>
● 胆固醇(CH)<br>
● 胆固醇酯(CE)<br>
● 脂肪酸(FA)<br>
● 磷脂(PL)<br>
</span>
<table>
  <tr>
    <td height="50%">
    <img src="/../img/生理药理学/第十五章/29.png" ><span style="display:block;text-align:center;">
<font size="4">
磷脂
</font>
    </span>
    </td>
    <td height="50%">
    <img src="/../img/生理药理学/第十五章/30.png" ><span style="display:block;text-align:center;">
<font size="4">
甘油三酯
</font>
    </span>
    </td>
  </tr>
</table>
<table>
  <tr>
    <td height="50%">
    <img src="/../img/生理药理学/第十五章/31.png" ><span style="display:block;text-align:center;">
<font size="4">
胆固醇
</font>
    </span>
    </td>
    <td height="50%">
    <img src="/../img/生理药理学/第十五章/32.png" ><span style="display:block;text-align:center;">
<font size="4">
胆固醇酯
</font>
    </span>
    </td>
    <td height="50%">
    <img src="/../img/生理药理学/第十五章/33.png" ><span style="display:block;text-align:center;">
<font size="4">
脂肪酸
</font>
    </span>
    </td>
  </tr>
</table>
<span style="color:#D81C2F">
脂蛋白<br>
● 球形。<br>
● 内部脂类分子。<br>
● 外部磷脂，胆固醇，载脂蛋白 (apolipoproteins, apo)。<br>
● 脂类分子在血液存在、运输、代谢的形式。
</span>

<p><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/34.png"><br>载脂蛋白<br>● 水溶性多肽。<br>● 已知多类具有不同功能的apo存在。<br>● 参与脂蛋白的代谢调节。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/35.png"><br><span style="color:#D81C2F"><br>脂蛋白种类<br>● 乳糜微粒 (CM)。<br>● 极低密度脂蛋白 (VLDL)。<br>● 低密度脂蛋白 (LDL)。<br>● 中间密度脂蛋白 (IDL)。<br>● 高密度脂蛋白 (HDL)。<br>● 脂蛋白(a) (LP(a))。<br></span><br><span style="color:#D81C2F"><br>脂蛋白生理功能<br>● 运输与代谢脂质。<br>● CM&#x2F;VLDL，甘油三酯，直径大，不易透过血管内膜，无致血管硬化。<br>● VLDL&#x2F;LDL&#x2F;IDL，富含胆固醇，运输肝脏合成的胆固醇到各处，部分可被血管壁摄取。<br>● HDL，最小颗粒，运输血管胆固醇至肝脏代谢，保护血管，“血管清道夫”。<br>● LP(a)，与LDL类似，增加动脉硬化。<br></span></p>
<table>
  <tr>
    <td height="50%"><img src="/../img/生理药理学/第十五章/36.png" ></td>
    <td height="50%"><img src="/../img/生理药理学/第十五章/37.png" ></td>
  </tr>
</table>

<p><em><strong>Good Cholesterol vs Bad Cholesterol</strong></em><br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/38.png"></p>
<h3 id="二、血脂异常与动脉硬化"><a href="#二、血脂异常与动脉硬化" class="headerlink" title="二、血脂异常与动脉硬化"></a>二、血脂异常与动脉硬化</h3><h4 id="1、原发性与继发性"><a href="#1、原发性与继发性" class="headerlink" title="1、原发性与继发性"></a><font size="4">1、原发性与继发性</font></h4><p><strong><span style="display:block;text-align:center;"><font size="4">原发性高脂血症的类型</font></span></strong></p>
<table>
<thead>
<tr>
<th>类型</th>
<th>升高的脂蛋白</th>
<th>CH</th>
<th>TG</th>
<th>致动脉粥样硬化的作用</th>
</tr>
</thead>
<tbody><tr>
<td>I</td>
<td>CM</td>
<td>+</td>
<td>+++</td>
<td>–</td>
</tr>
<tr>
<td>IIa</td>
<td>LDL</td>
<td>++</td>
<td>–</td>
<td>高度</td>
</tr>
<tr>
<td>IIb</td>
<td>LDL, VLDL</td>
<td>++</td>
<td>++</td>
<td>高度</td>
</tr>
<tr>
<td>III</td>
<td>IDL</td>
<td>+</td>
<td>++</td>
<td>中度</td>
</tr>
<tr>
<td>IV</td>
<td>VLDL</td>
<td>+</td>
<td>++</td>
<td>中度</td>
</tr>
<tr>
<td>V</td>
<td>CM, VLDL</td>
<td>+</td>
<td>+++</td>
<td>–</td>
</tr>
</tbody></table>
<p><strong>注：“+”代表轻度升高，“++”代表中度升高，“+++”代表重度升高，“–”代表没变化。</strong></p>
<h4 id="2、动脉硬化的影响因素"><a href="#2、动脉硬化的影响因素" class="headerlink" title="2、动脉硬化的影响因素"></a><font size="4">2、动脉硬化的影响因素</font></h4><p>● 高血脂：甘油三酯和胆固醇<br>● 高血压：损伤血管内膜壁<br>● 抽烟：升高脂肪酸与胆固醇含量<br>● 糖尿病：脂质代谢紊乱<br>● 其它：年龄、肥胖、饮酒等<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/39.png"><br><span style="display:block;text-align:center;"><br><font size="4"><br>Saturated and unsaturated fatty acids<br></font><br></span><br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/40.png"></p>
<span style="display:block;text-align:center;">
<font size="4">
trans or cis unsaturated fatty acids
</font>
</span>

<p><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/41.png"></p>
<h3 id="三、抗动脉硬化药"><a href="#三、抗动脉硬化药" class="headerlink" title="三、抗动脉硬化药"></a>三、抗动脉硬化药</h3><h4 id="（一）治疗策略"><a href="#（一）治疗策略" class="headerlink" title="（一）治疗策略"></a><font size="4">（一）治疗策略</font></h4><p>● 降血脂<br>● 阻滞胆汁酸的肝肠循环<br>● 肠道胆固醇到肝转运抑制剂<br>● 阻断脂质过氧化<br>● 增加脂蛋白酯酶活性<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/42.png"></p>
<h4 id="（二）降血脂药"><a href="#（二）降血脂药" class="headerlink" title="（二）降血脂药"></a><font size="4"><span style="color:#D81C2F">（二）降血脂药</span></font></h4><h5 id="1、他汀类药物"><a href="#1、他汀类药物" class="headerlink" title="1、他汀类药物"></a><font size="4"><span style="color:#D81C2F">1、他汀类药物</span></font></h5><span style="color:#D81C2F">
抑制羟甲基戊二酸单酰辅酶A (HMG-CoA)还原酶，减少内源性胆固醇的合成。
</span>

<p><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/43.png"><br>● 洛伐他汀<br>● 辛伐他汀<br>● 普伐他汀<br>● 氟伐他汀<br>● 阿托伐他汀<br>● 瑞舒伐他汀<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/44.png"></p>
<h5 id="2、胆汁酸结合树脂"><a href="#2、胆汁酸结合树脂" class="headerlink" title="2、胆汁酸结合树脂"></a><font size="4">2、胆汁酸结合树脂</font></h5><p>● 肠道内吸附胆汁酸，阻滞肝脏重吸收。<br>● 促进内源性胆固醇肝脏内代谢。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/46.png"><br>● 不溶于水，不良作用多。<br>● 考来烯胺 (cholestyramine)。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/45.png"></p>
<h5 id="3、胆固醇吸收抑制剂"><a href="#3、胆固醇吸收抑制剂" class="headerlink" title="3、胆固醇吸收抑制剂"></a><font size="4">3、胆固醇吸收抑制剂</font></h5><p>● 抑制小肠细胞表达的NPC1L1胆固醇转运蛋白。<br>● 选择性抑制饮食和胆汁中的胆固醇跨小肠壁转运到肝脏。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/48.png"></p>
<table>
  <tr>
    <td height="50%">
    <img src="/../img/生理药理学/第十五章/47.png" ><span style="display:block;text-align:center;">
<font size="4">
依折麦布
</font>
    </span>
    </td>
  </tr>
</table>

<h5 id="4、抗氧化剂"><a href="#4、抗氧化剂" class="headerlink" title="4、抗氧化剂"></a><font size="4">4、抗氧化剂</font></h5><p>● 阻断血管脂质过氧化。<br>● 减少脂质过氧化物引起的血管内细胞粘附、内皮细胞损伤等。<br>● 清除氧自由基。<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/49.png"></p>
<h5 id="5、PCSK9抑制剂"><a href="#5、PCSK9抑制剂" class="headerlink" title="5、PCSK9抑制剂"></a><font size="4">5、PCSK9抑制剂</font></h5><p>● PCSK9为前蛋白转移酶<br>● 肝脏、小肠、肾表达<br>● 抑制剂阻滞PCSK与LDL受体的结合<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/50.png"><br><strong>抑制PCSK9结合</strong><br>● LDL受体接受血管内LDL结合<br>● 摄取LDL到细胞内并代谢分解<br>● LDL受体再利用<br><strong>PCSK9结合</strong><br>● PCSK9特异结合LDL受体<br>● 移至溶酶体<br>● 受体被降解<br>● LDLR无法再利用<br>● 血液中LDL浓度升高<br><img src="/../img/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/51.png"></p>
<h1 id="本章小结"><a href="#本章小结" class="headerlink" title="本章小结"></a>本章小结</h1><p>1、<a href="#%E4%BA%8C%E3%80%81%E5%BF%83%E8%84%8F%E7%9A%84%E7%94%B5%E7%94%9F%E7%90%86">心脏电生理</a><br>2、<a href="#%E4%B8%89%E3%80%81%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8%E7%9A%84%E5%8F%91%E7%94%9F%E6%9C%BA%E5%88%B6">心律失常发生的机制</a><br>3、<a href="#%E4%BA%94%E3%80%81%E5%B8%B8%E8%A7%81%E6%8A%97%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8%E8%8D%AF%E7%89%A9">抗心律失常药物分类以及作用机制</a> </p>
<p>4、<a href="#%E4%B8%80%E3%80%81%E8%A1%80%E8%84%82%E4%BB%A3%E8%B0%A2%E7%94%9F%E7%90%86%E5%AD%A6">血脂</a>、<a href="#%E4%B8%80%E3%80%81%E8%A1%80%E8%84%82%E4%BB%A3%E8%B0%A2%E7%94%9F%E7%90%86%E5%AD%A6">脂蛋白</a>、以及它们的生理功能<br>5、动脉硬化的<a href="#2%E3%80%81%E5%8A%A8%E8%84%89%E7%A1%AC%E5%8C%96%E7%9A%84%E5%BD%B1%E5%93%8D%E5%9B%A0%E7%B4%A0">影响因素</a>以及<a href="#%EF%BC%88%E4%B8%80%EF%BC%89%E6%B2%BB%E7%96%97%E7%AD%96%E7%95%A5">治疗策略</a><br>6、<a href="#1%E3%80%81%E4%BB%96%E6%B1%80%E7%B1%BB%E8%8D%AF%E7%89%A9">他汀类降血脂药的作用机制</a></p>
</article><div class="post-copyright"><div class="post-copyright__author"><span class="post-copyright-meta"><i class="fas fa-circle-user fa-fw"></i>Author: </span><span class="post-copyright-info"><a href="https://blog.yediao.dpdns.org">夜雕</a></span></div><div class="post-copyright__type"><span class="post-copyright-meta"><i class="fas fa-square-arrow-up-right fa-fw"></i>Link: </span><span class="post-copyright-info"><a href="https://blog.yediao.dpdns.org/2025/05/08/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/">https://blog.yediao.dpdns.org/2025/05/08/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0/</a></span></div><div class="post-copyright__notice"><span class="post-copyright-meta"><i class="fas fa-circle-exclamation fa-fw"></i>Copyright Notice: </span><span class="post-copyright-info">All articles on this blog are licensed under <a target="_blank" rel="noopener" href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> unless otherwise stated.</span></div></div><div class="tag_share"><div class="post-meta__tag-list"><a class="post-meta__tags" href="/tags/%E5%AD%A6%E4%B9%A0%E7%AC%94%E8%AE%B0/">学习笔记</a><a class="post-meta__tags" href="/tags/%E7%94%9F%E7%89%A9%E5%88%B6%E8%8D%AF/">生物制药</a><a class="post-meta__tags" href="/tags/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6/">生理药理学</a></div><div class="post-share"><div class="social-share" data-image="/img/s1.png" data-sites="facebook,twitter,wechat,weibo,qq"></div><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/butterfly-extsrc/sharejs/dist/css/share.min.css" media="print" onload="this.media='all'"><script src="https://cdn.jsdelivr.net/npm/butterfly-extsrc/sharejs/dist/js/social-share.min.js" defer></script></div></div><nav class="pagination-post" id="pagination"><a class="pagination-related" href="/2025/05/01/%E8%99%B9%E5%92%B2%E6%9C%AA%E6%9D%A5%E5%9C%B0%E5%9B%BE%E8%A1%A5%E4%B8%81%E5%88%B6%E4%BD%9C/" title="虹咲未来地图汉化补丁制作"><img class="cover" src="/img/s1.png" onerror="onerror=null;src='/img/404.jpg'" alt="cover of previous post"><div class="info"><div class="info-1"><div class="info-item-1">Previous</div><div class="info-item-2">虹咲未来地图汉化补丁制作</div></div><div class="info-2"><div class="info-item-1">前言本次汉化补丁靠的是大家的共同努力，才能在五一前完成测试并上线。我在这次补丁的制作中主要搞的是翻译和后期打包以及测试本文记载的是打包遇到的各种状况，为日后遇到类似问题时可以提供参考思路特别感谢在这里要特别感谢凌空和某魏两位大佬开发出的解包和打包工具以及最初的解包文件，使得字幕组可以在二月份就对文本进行汉化作业。（因为一些奇奇怪怪的原因导致4月中快发售了才想起来要做图片的嵌字部分）完整解包流程阶段一：解包文件使用某魏制作的py脚本对游戏的hdlg和hpb等文件进行解包 阶段二：资源提取文本提取使用hdlg2txt.py 1python hdlg2txt.py script_dialog_ja.hdlg 可得到script_dialog_ja.hdlg.txt，里面就是游戏的日文原文文本了。 图形资源处理同理，使用hpb_unpack.py处理data.hpb和data.hph 1python hpb_unpack.py...</div></div></div></a><a class="pagination-related" href="/2025/05/12/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6%E7%AC%AC%E5%8D%81%E5%85%AD%E7%AB%A0/" title="生理药理学第十六章"><img class="cover" src="/img/s1.png" onerror="onerror=null;src='/img/404.jpg'" alt="cover of next post"><div class="info text-right"><div class="info-1"><div class="info-item-1">Next</div><div class="info-item-2">生理药理学第十六章</div></div><div class="info-2"><div class="info-item-1">第十六章 解热镇疼抗炎药物第一节 膜磷脂-花生四烯酸代谢通路 ● 膜磷脂主要通过花生四烯酸通路代谢 ● 三代谢途径：环加氧酶(COX)途径、脂加氧酶(LOX)途径、P450表氧化酶途径 ● 三类代谢物：前列腺素类(PGs)、血栓素类(TXs)、白三烯类(LTs)。                 花生四烯酸                  1、前列腺素 (Prostaglandins, PGs)● 一类生理活性物质● 普遍存在人体各个组织● 通过不同的PG受体，产生激素样生理影响● 20碳，包括一个五元环                PGE1                  2、血栓素 (Thromboxanes,TXs)● 脂质家族● 主要成员，TXA2、TXB2● 在血栓形成中扮演作用● 6元环，TXA2含有一个6元含醚环                TXA2                  TXB2           由活化的血小板产生的血栓素 A2 (TXA2) 具有促进血栓形成的特性，可刺激新血小板的活化以及增加血小板聚集。 TXB2 是 TXA2...</div></div></div></a></nav><div class="relatedPosts"><div class="headline"><i class="fas fa-thumbs-up fa-fw"></i><span>Related Articles</span></div><div class="relatedPosts-list"><a class="pagination-related" href="/2025/06/27/%E7%94%9F%E7%90%86%E5%AD%A6%E5%A4%8D%E4%B9%A0%E9%83%A8%E5%88%86/" title="生理学复习部分"><img class="cover" src="/img/s1.png" alt="cover"><div class="info text-center"><div class="info-1"><div class="info-item-1"><i class="far fa-calendar-alt fa-fw"></i> 2025-06-27</div><div class="info-item-2">生理学复习部分</div></div><div class="info-2"><div class="info-item-1">生理学复习【第二章】跨细胞膜物质转运途径：1.单纯扩散2.易化扩散：经通道扩散、经载体扩散3.主动转运：原发性、继发性4.膜泡运输：出胞、入胞 细胞信号转导途径：1.膜受体信号转导：离子通道型、G蛋白耦联型、酶联型、招募型2.核受体信号转导。 第二信使：激素、神经递质等胞外信使分子作用于膜受体后产生的胞内信使分子。RP：静息电位，静息状态下胞膜两侧内负外正的电位差。AP：动作电位，细胞在静息电位基础上接受有效刺激后产生的可迅速向远处传播的膜电位波动。LP：局部电位，细胞受刺激后，部分离子通道开放形成的、不能向远处传播的膜电位波动TP：阈电位，能触发动作电位的膜电位临界值。 细胞兴奋性周期包括：绝对不应期、相对不应期、超常期、低常期。 动作电位特点：全或无现象、不衰减传导、脉冲式 局部电位特点：电位幅度与刺激强度相关，可叠加总和，无“全或无”；衰减传导；无“不应期” 骨骼肌神经-肌接头的兴奋传递过程：运动神经末梢动作电位 → 突触前膜去极化 → 电压门控钙通道开放 → 钙内流 → 突触前膜囊泡出胞释放ACh → 激活突触后膜N2受体离子通道 → 钠通道开放 → 突触后膜钠内流 →...</div></div></div></a><a class="pagination-related" href="/2025/03/28/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6%E7%AC%AC%E4%B8%80%E7%AB%A0/" title="生理药理学第一章"><img class="cover" src="/img/s1.png" alt="cover"><div class="info text-center"><div class="info-1"><div class="info-item-1"><i class="far fa-calendar-alt fa-fw"></i> 2025-03-28</div><div class="info-item-2">生理药理学第一章</div></div><div class="info-2"><div class="info-item-1">第一章 药理学总论药理学：研究药物在人体或动物体内的作用、机制、以及规律的学科。药物：对机体生理、生化、病理过程产生影响，并用于治疗的化学分子。 第一节  药理学的研究内容与研究方法1、药理学是一门综合学科● 学科基础：生理学、生物化学、细胞生物学、微生物学、病理学、免疫学、以及其它相关学科。● 所处地位：基础医学与临床医学之间的桥梁。 2、研究内容● 药物效应动力学(Pharmacodynamics)： 药物对机体的作用与作用机制。● 药物代谢动力学 (Pharmacokinetics)：机体对药物的代谢过程。● 常见的术语：副作用 (side effects or adverse effects)毒性 (toxicity)阴性对照 (vehicle or placebo)阳性对照 (positive control)作用机理 (mechanism of action)药物 (drug)激动剂(agonist)拮抗剂(antagonist) 3、研究方法● 体外实验(in vitro)● 体内实验(in vivo)● 离体实验(ex vivo) 研究层次●...</div></div></div></a><a class="pagination-related" href="/2025/06/12/%E7%94%9F%E7%90%86%E5%AD%A6%E7%9F%A5%E8%AF%86%E8%A1%A5%E5%85%85/" title="生理学知识补充"><img class="cover" src="/img/s1.png" alt="cover"><div class="info text-center"><div class="info-1"><div class="info-item-1"><i class="far fa-calendar-alt fa-fw"></i> 2025-06-12</div><div class="info-item-2">生理学知识补充</div></div><div class="info-2"><div class="info-item-1">生理学知识补充一、受体脱敏：在长期使用一种激动药后，组织或细胞对激动药的敏感性和反应性下降的现象。 二、生物利用度：经任何给药途径给予一定剂量的药物后到达全身血循环内药物的百分率称生物利用度，即生物利用度&#x3D;A&#x2F;D×100%（A为体内药物总量，D为用药剂量）。 三、肾小球滤过：血液流经肾小球毛细血管，除蛋白外，其余成分均能滤过进入肾小囊腔生成超滤液，是尿生成的第一步。  四、胃排空：食物由胃排入十二指肠的过程。 五、肾单位：由肾小体和肾小管构成，肾小体由肾小球和肾小囊组成。 六、允许作用：一种激素对其他激素的支持作用。 七、血细胞比容：血细胞在血液中所占的容积百分比。 八、小脑对运动的调节：前庭小脑：维持身体平衡；脊髓小脑：协调随意运动、调整肌紧张；皮层小脑：参与编辑随意运动。 九，骨骼肌神经-肌接头的兴奋传递过程。运动神经末梢动作电位 - 接头前膜去极化 - 电压门控钙通道开放 - 钙内流-接头前膜囊泡出胞释放ACh -  激活接头后膜N2受体离子通道 – 钠通道开放 – 接头后膜钠内流 – 后膜去极化产生终板电位 – 电紧张扩步 – 总和达阈电位 –...</div></div></div></a><a class="pagination-related" href="/2025/06/22/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6%E6%B1%87%E6%80%BB/" title="生理药理学汇总"><img class="cover" src="/img/s1.png" alt="cover"><div class="info text-center"><div class="info-1"><div class="info-item-1"><i class="far fa-calendar-alt fa-fw"></i> 2025-06-22</div><div class="info-item-2">生理药理学汇总</div></div><div class="info-2"><div class="info-item-1">药理学汇总【第二章】药物的体内过程ADME，包括：吸收、分布、代谢、排泄 药物转运方式1.被动转运：简单扩散、易化扩散2.主动转运：原发性主动转运、继发性主动转运3.膜动转运：胞饮、胞吐 吸收：药物由给药部位进入血液循环。影响吸收的因素：药物理化性质、剂型、给药途径、吸收部位血流量 首关效应（首过消除）：药物口服后首次通过肠壁或肝时被酶代谢，使进入体循环的有效药量减少。 分布：药物吸收后随血液循环到达组织器官。影响分布的因素：血浆蛋白结合率、细胞膜屏障、体液pH和药物解离度、器官血流量和膜通透性、药物组织亲和力、药物转运体 代谢：药物在体内发生化学结构改变代谢过程包括两相反应：I相-氧化还原水解；II相-极性基团结合影响代谢的因素：遗传因素、生理因素、营养状态、环境因素（酶诱导因素、抑制因素） 排泄：药物及其代谢物通过排泄器官被排出体外 生物利用度：药物活性成分释放吸收进入血液循环的程度和速度 肝药酶：细胞色素P450...</div></div></div></a><a class="pagination-related" href="/2025/06/22/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6%E5%A4%8D%E4%B9%A0%E7%B2%BE%E7%AE%80%E7%89%88/" title="生理药理学复习精简版"><img class="cover" src="/img/s1.png" alt="cover"><div class="info text-center"><div class="info-1"><div class="info-item-1"><i class="far fa-calendar-alt fa-fw"></i> 2025-06-22</div><div class="info-item-2">生理药理学复习精简版</div></div><div class="info-2"><div class="info-item-1">药理学复习【第二章】药物的体内过程ADME，包括：吸收、分布、代谢、排泄 药物转运方式1.被动转运：简单扩散、易化扩散2.主动转运：原发性主动转运、继发性主动转运3.膜动转运：胞饮、胞吐 吸收：药物由给药部位进入血液循环。影响吸收的因素：药物理化性质、剂型、给药途径、吸收部位血流量 首关效应（首过消除）：药物口服后首次通过肠壁或肝时被酶代谢，使进入体循环的有效药量减少。 分布：药物吸收后随血液循环到达组织器官。影响分布的因素：血浆蛋白结合率、细胞膜屏障、体液pH和药物解离度、器官血流量和膜通透性、药物组织亲和力、药物转运体 代谢：药物在体内发生化学结构改变代谢过程包括两相反应：I相-氧化还原水解；II相-极性基团结合影响代谢的因素：遗传因素、生理因素、营养状态、环境因素（酶诱导因素、抑制因素） 排泄：药物及其代谢物通过排泄器官被排出体外 生物利用度：药物活性成分释放吸收进入血液循环的程度和速度 肝药酶：细胞色素P450...</div></div></div></a><a class="pagination-related" href="/2025/06/12/%E7%94%9F%E7%90%86%E8%8D%AF%E7%90%86%E5%AD%A6%E7%AC%AC%E4%BA%8C%E5%8D%81%E4%BA%8C%E7%AB%A0/" title="生理药理学第二十二章"><img class="cover" src="/img/s1.png" alt="cover"><div class="info text-center"><div class="info-1"><div class="info-item-1"><i class="far fa-calendar-alt fa-fw"></i> 2025-06-12</div><div class="info-item-2">生理药理学第二十二章</div></div><div class="info-2"><div class="info-item-1">第二十二章 组胺受体拮抗药一、组胺以及其受体1、组胺● 自体活性物质。● 组氨酸经组氨酸脱羧酶催化而来。● 组胺在变应性鼻炎、荨麻疹、血管神经性水肿等疾病的病变机理起重要作用。● 组胺在大脑中作为神经递质或神经调质起作用。 2、组胺受体●  四种受体，H1、H2、H3、H4。● 均为G蛋白偶联受体。● 组织分布不同，生理作用不同。 3、组胺的药理作用● 心血管：扩张血管 (H1、H2)● 平滑肌：兴奋支气管平滑肌 （H1）● 腺体：胃酸分泌 (H2)● 神经末端：痛与痒 (H1)● 中枢神经：觉醒 二、H1受体拮抗药第一代：苯海拉明、异丙嗪 （中枢镇静副作用）第二代：氯雷他定、西替利嗪  1、药理作用● H1受体拮抗：肠胃道、支气管、子宫平滑肌的痉挛性收缩有拮抗作用。● 抗胆碱作用：中枢镇静、镇吐。● 中枢作用：第一代具有镇静催眠作用。● 其它：局麻以及微弱的α受体拮抗作用。 2、临床应用● 荨麻疹● 变应性鼻炎● 昆虫咬伤、药物性、接触性皮炎● 晕动与呕吐 三、H2 受体拮抗药药理● 特异性拮抗胃壁细胞H2受体，阻滞胃酸分泌。 临床●...</div></div></div></a></div></div><hr class="custom-hr"/><div id="post-comment"><div class="comment-head"><div class="comment-headline"><i class="fas fa-comments fa-fw"></i><span> Comments</span></div></div><div class="comment-wrap"><div><div id="gitalk-container"></div></div></div></div></div><div class="aside-content" id="aside-content"><div class="card-widget card-info text-center"><div class="avatar-img"><img src="/img/%E8%99%B9%E5%92%B2.ico" onerror="this.onerror=null;this.src='/img/404.jpg'" alt="avatar"/></div><div class="author-info-name">夜雕</div><div class="author-info-description"></div><div class="site-data"><a href="/archives/"><div class="headline">Articles</div><div class="length-num">36</div></a><a href="/tags/"><div class="headline">Tags</div><div class="length-num">12</div></a><a href="/categories/"><div class="headline">Categories</div><div class="length-num">0</div></a></div><a id="card-info-btn" target="_blank" rel="noopener" href="https://github.com/lf12306"><i class="fab fa-github"></i><span>Follow Me</span></a></div><div class="card-widget" id="currency-converter"><div class="item-headline"><i class="fas fa-exchange-alt"></i><span>货币换算</span></div><div class="currency-converter-container"><!-- DO NOT EDIT THIS CODE; START CURRENCY CONVERTER WIDGET-->
<a target="_blank" href="https://www.currency.wiki/" rel="nofollow noopener" id="currency-wiki-link" style="display:none">Currency.Wiki</a>
<script>
  document.addEventListener('DOMContentLoaded', function() {
    // 动态加载小工具脚本
    var script = document.createElement('script');
    script.src = 'https://www.currency.wiki/widget/embed?f=JPY&t=CNY&a=100&fc=ffffff&c=84c36e&g=on&sh=on&b=off&fl=on&p=e&cs=JPY,CNY&s=right&mf=1&df=4&d=1&su=on&l=https://www.currency.wiki/&cd=8808907ce2483e3b39325779c309c812&lang=zh-CN';
    script.async = true;
    document.getElementById('currency-wiki-link').parentNode.appendChild(script);
  });
</script>
<!-- DO NOT EDIT THIS CODE; END CURRENCY CONVERTER WIDGET--></div></div><div class="card-widget card-announcement"><div class="item-headline"><img class="icon-shake fa-shake" src="/img/icon/shizuku.ico"/><span>Announcement</span></div><div class="announcement_content">在不完美的世界中，为那些追求美好的人们应援</div></div><div class="sticky_layout"><div class="card-widget" id="card-toc"><div class="item-headline"><i class="fas fa-stream"></i><span>Contents</span><span class="toc-percentage"></span></div><div class="toc-content"><ol class="toc"><li class="toc-item toc-level-1"><a class="toc-link" href="#%E7%AC%AC%E5%8D%81%E4%BA%94%E7%AB%A0-%E6%8A%97%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8%E3%80%81%E6%8A%97%E5%8A%A8%E8%84%89%E7%A1%AC%E5%8C%96%E8%8D%AF"><span class="toc-number">1.</span> <span class="toc-text">第十五章 抗心律失常、抗动脉硬化药</span></a><ol class="toc-child"><li class="toc-item toc-level-2"><a class="toc-link" href="#%E7%AC%AC%E4%B8%80%E8%8A%82-%E6%8A%97%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8%E8%8D%AF"><span class="toc-number">1.1.</span> <span class="toc-text">第一节 抗心律失常药</span></a><ol class="toc-child"><li class="toc-item toc-level-3"><a class="toc-link" href="#%E4%B8%80%E3%80%81%E8%86%9C%E7%94%B5%E4%BD%8D%E7%9A%84%E5%9F%BA%E6%9C%AC%E7%9F%A5%E8%AF%86"><span class="toc-number">1.1.1.</span> <span class="toc-text">一、膜电位的基本知识</span></a><ol class="toc-child"><li class="toc-item toc-level-4"><a class="toc-link" href="#1%E3%80%81%E9%9D%99%E6%81%AF%E7%94%B5%E4%BD%8D-Resting-Potential-RP"><span class="toc-number">1.1.1.1.</span> <span class="toc-text">1、静息电位 (Resting Potential, RP)</span></a></li><li class="toc-item toc-level-4"><a class="toc-link" href="#2%E3%80%81%E5%8A%A8%E4%BD%9C%E7%94%B5%E4%BD%8D-Action-Potential-AP"><span class="toc-number">1.1.1.2.</span> <span class="toc-text">2、动作电位 (Action Potential, AP)</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%881%EF%BC%89%E5%B1%80%E9%83%A8%E7%94%B5%E4%BD%8D%EF%BC%9A%E7%94%B1%E5%85%B4%E5%A5%8B%E5%BC%95%E8%B5%B7%E7%9A%84%E7%94%B5%E7%B4%A7%E5%BC%A0%E7%94%B5%E4%BD%8D%E3%80%82"><span class="toc-number">1.1.1.2.1.</span> <span class="toc-text">（1）局部电位：由兴奋引起的电紧张电位。</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%882%EF%BC%89%E5%8A%A8%E4%BD%9C%E7%94%B5%E4%BD%8D-Action-Potential-AP"><span class="toc-number">1.1.1.2.2.</span> <span class="toc-text">（2）动作电位 (Action Potential, AP)</span></a></li></ol></li></ol></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E4%BA%8C%E3%80%81%E5%BF%83%E8%84%8F%E7%9A%84%E7%94%B5%E7%94%9F%E7%90%86"><span class="toc-number">1.1.2.</span> <span class="toc-text">二、心脏的电生理</span></a></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E4%B8%89%E3%80%81%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8%E7%9A%84%E5%8F%91%E7%94%9F%E6%9C%BA%E5%88%B6"><span class="toc-number">1.1.3.</span> <span class="toc-text">三、心律失常的发生机制</span></a><ol class="toc-child"><li class="toc-item toc-level-4"><a class="toc-link" href="#1%E3%80%81%E8%87%AA%E5%BE%8B%E6%80%A7%E5%8D%87%E9%AB%98"><span class="toc-number">1.1.3.1.</span> <span class="toc-text">1、自律性升高</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%881%EF%BC%89%E8%87%AA%E5%BE%8B%E6%80%A7"><span class="toc-number">1.1.3.1.1.</span> <span class="toc-text">（1）自律性</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%882%EF%BC%89%E5%BD%B1%E5%93%8D%E8%87%AA%E5%BE%8B%E6%80%A7%E7%9A%84%E5%9B%A0%E7%B4%A0"><span class="toc-number">1.1.3.1.2.</span> <span class="toc-text">（2）影响自律性的因素</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%883%EF%BC%89%E8%87%AA%E5%BE%8B%E6%80%A7%E5%8D%87%E9%AB%98%E5%8E%9F%E5%9B%A0"><span class="toc-number">1.1.3.1.3.</span> <span class="toc-text">（3）自律性升高原因</span></a></li></ol></li><li class="toc-item toc-level-4"><a class="toc-link" href="#2%E3%80%81%E8%A7%A6%E5%8F%91%E6%B4%BB%E5%8A%A8"><span class="toc-number">1.1.3.2.</span> <span class="toc-text">2、触发活动</span></a></li><li class="toc-item toc-level-4"><a class="toc-link" href="#3%E3%80%81%E5%86%B2%E5%8A%A8%E4%BC%A0%E5%AF%BC%E9%9A%9C%E7%A2%8D-%E6%8A%98%E8%BF%94%E6%BF%80%E5%8A%A8"><span class="toc-number">1.1.3.3.</span> <span class="toc-text">3、冲动传导障碍 (折返激动)</span></a></li></ol></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E5%9B%9B%E3%80%81%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8%E6%B2%BB%E7%96%97%E7%AD%96%E7%95%A5"><span class="toc-number">1.1.4.</span> <span class="toc-text">四、心律失常治疗策略</span></a><ol class="toc-child"><li class="toc-item toc-level-4"><a class="toc-link" href="#1%E3%80%81%E9%9D%9E%E8%8D%AF%E7%89%A9%E6%B2%BB%E7%96%97"><span class="toc-number">1.1.4.1.</span> <span class="toc-text">1、非药物治疗</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%881%EF%BC%89%E8%B5%B7%E6%90%8F%E5%99%A8"><span class="toc-number">1.1.4.1.1.</span> <span class="toc-text">（1）起搏器</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%882%EF%BC%89%E5%AF%BC%E7%AE%A1%E6%B6%88%E8%9E%8D%E5%92%8C%E6%89%8B%E6%9C%AF"><span class="toc-number">1.1.4.1.2.</span> <span class="toc-text">（2）导管消融和手术</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%883%EF%BC%89%E7%94%B5%E5%A4%8D%E5%BE%8B-%E5%BF%83%E8%84%8F%E7%94%B5%E9%99%A4%E9%A2%A4"><span class="toc-number">1.1.4.1.3.</span> <span class="toc-text">（3）电复律(心脏电除颤)</span></a></li></ol></li><li class="toc-item toc-level-4"><a class="toc-link" href="#2%E3%80%81%E8%8D%AF%E7%89%A9%E6%B2%BB%E7%96%97-%E5%8F%8C%E5%88%83%E5%89%91"><span class="toc-number">1.1.4.2.</span> <span class="toc-text">2、药物治疗 (双刃剑)</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%881%EF%BC%89%E9%99%8D%E4%BD%8E%E8%87%AA%E5%BE%8B%E6%80%A7"><span class="toc-number">1.1.4.2.1.</span> <span class="toc-text">（1）降低自律性</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%882%EF%BC%89%E5%87%8F%E5%B0%91%E5%90%8E%E9%99%A4%E6%9E%81"><span class="toc-number">1.1.4.2.2.</span> <span class="toc-text">（2）减少后除极</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#%EF%BC%883%EF%BC%89%E6%B6%88%E9%99%A4%E6%8A%98%E8%BF%94"><span class="toc-number">1.1.4.2.3.</span> <span class="toc-text">（3）消除折返</span></a></li></ol></li></ol></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E4%BA%94%E3%80%81%E5%B8%B8%E8%A7%81%E6%8A%97%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8%E8%8D%AF%E7%89%A9"><span class="toc-number">1.1.5.</span> <span class="toc-text">五、常见抗心律失常药物</span></a><ol class="toc-child"><li class="toc-item toc-level-4"><a class="toc-link" href="#%EF%BC%88%E4%B8%80%EF%BC%89%E9%92%A0%E9%80%9A%E9%81%93%E9%98%BB%E6%BB%9E%E8%8D%AF-I%E7%B1%BB"><span class="toc-number">1.1.5.1.</span> <span class="toc-text">（一）钠通道阻滞药 (I类)</span></a></li><li class="toc-item toc-level-4"><a class="toc-link" href="#%EF%BC%88%E4%BA%8C%EF%BC%89%CE%B2%E8%82%BE%E4%B8%8A%E8%85%BA%E7%B4%A0%E5%8F%97%E4%BD%93%E9%98%BB%E6%96%AD%E8%8D%AF"><span class="toc-number">1.1.5.2.</span> <span class="toc-text">（二）β肾上腺素受体阻断药</span></a></li><li class="toc-item toc-level-4"><a class="toc-link" href="#%EF%BC%88%E4%B8%89%EF%BC%89%E5%BB%B6%E9%95%BF%E5%8A%A8%E4%BD%9C%E7%94%B5%E4%BD%8D%E6%97%B6%E7%A8%8B%E8%8D%AF"><span class="toc-number">1.1.5.3.</span> <span class="toc-text">（三）延长动作电位时程药</span></a></li><li class="toc-item toc-level-4"><a class="toc-link" href="#%EF%BC%88%E5%9B%9B%EF%BC%89%E9%92%99%E9%80%9A%E9%81%93%E9%98%BB%E6%BB%9E%E5%89%82"><span class="toc-number">1.1.5.4.</span> <span class="toc-text">（四）钙通道阻滞剂</span></a></li></ol></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E5%85%AD%E3%80%81%E6%8A%97%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8%E7%94%A8%E8%8D%AF%E5%8E%9F%E5%88%99"><span class="toc-number">1.1.6.</span> <span class="toc-text">六、抗心律失常用药原则</span></a></li></ol></li><li class="toc-item toc-level-2"><a class="toc-link" href="#%E7%AC%AC%E4%BA%8C%E8%8A%82-%E6%8A%97%E5%8A%A8%E8%84%89%E7%A1%AC%E5%8C%96%E8%8D%AF"><span class="toc-number">1.2.</span> <span class="toc-text">第二节 抗动脉硬化药</span></a><ol class="toc-child"><li class="toc-item toc-level-3"><a class="toc-link" href="#%E4%B8%80%E3%80%81%E8%A1%80%E8%84%82%E4%BB%A3%E8%B0%A2%E7%94%9F%E7%90%86%E5%AD%A6"><span class="toc-number">1.2.1.</span> <span class="toc-text">一、血脂代谢生理学</span></a></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E4%BA%8C%E3%80%81%E8%A1%80%E8%84%82%E5%BC%82%E5%B8%B8%E4%B8%8E%E5%8A%A8%E8%84%89%E7%A1%AC%E5%8C%96"><span class="toc-number">1.2.2.</span> <span class="toc-text">二、血脂异常与动脉硬化</span></a><ol class="toc-child"><li class="toc-item toc-level-4"><a class="toc-link" href="#1%E3%80%81%E5%8E%9F%E5%8F%91%E6%80%A7%E4%B8%8E%E7%BB%A7%E5%8F%91%E6%80%A7"><span class="toc-number">1.2.2.1.</span> <span class="toc-text">1、原发性与继发性</span></a></li><li class="toc-item toc-level-4"><a class="toc-link" href="#2%E3%80%81%E5%8A%A8%E8%84%89%E7%A1%AC%E5%8C%96%E7%9A%84%E5%BD%B1%E5%93%8D%E5%9B%A0%E7%B4%A0"><span class="toc-number">1.2.2.2.</span> <span class="toc-text">2、动脉硬化的影响因素</span></a></li></ol></li><li class="toc-item toc-level-3"><a class="toc-link" href="#%E4%B8%89%E3%80%81%E6%8A%97%E5%8A%A8%E8%84%89%E7%A1%AC%E5%8C%96%E8%8D%AF"><span class="toc-number">1.2.3.</span> <span class="toc-text">三、抗动脉硬化药</span></a><ol class="toc-child"><li class="toc-item toc-level-4"><a class="toc-link" href="#%EF%BC%88%E4%B8%80%EF%BC%89%E6%B2%BB%E7%96%97%E7%AD%96%E7%95%A5"><span class="toc-number">1.2.3.1.</span> <span class="toc-text">（一）治疗策略</span></a></li><li class="toc-item toc-level-4"><a class="toc-link" href="#%EF%BC%88%E4%BA%8C%EF%BC%89%E9%99%8D%E8%A1%80%E8%84%82%E8%8D%AF"><span class="toc-number">1.2.3.2.</span> <span class="toc-text">（二）降血脂药</span></a><ol class="toc-child"><li class="toc-item toc-level-5"><a class="toc-link" href="#1%E3%80%81%E4%BB%96%E6%B1%80%E7%B1%BB%E8%8D%AF%E7%89%A9"><span class="toc-number">1.2.3.2.1.</span> <span class="toc-text">1、他汀类药物</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#2%E3%80%81%E8%83%86%E6%B1%81%E9%85%B8%E7%BB%93%E5%90%88%E6%A0%91%E8%84%82"><span class="toc-number">1.2.3.2.2.</span> <span class="toc-text">2、胆汁酸结合树脂</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#3%E3%80%81%E8%83%86%E5%9B%BA%E9%86%87%E5%90%B8%E6%94%B6%E6%8A%91%E5%88%B6%E5%89%82"><span class="toc-number">1.2.3.2.3.</span> <span class="toc-text">3、胆固醇吸收抑制剂</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#4%E3%80%81%E6%8A%97%E6%B0%A7%E5%8C%96%E5%89%82"><span class="toc-number">1.2.3.2.4.</span> <span class="toc-text">4、抗氧化剂</span></a></li><li class="toc-item toc-level-5"><a class="toc-link" href="#5%E3%80%81PCSK9%E6%8A%91%E5%88%B6%E5%89%82"><span class="toc-number">1.2.3.2.5.</span> <span class="toc-text">5、PCSK9抑制剂</span></a></li></ol></li></ol></li></ol></li></ol></li><li class="toc-item toc-level-1"><a class="toc-link" href="#%E6%9C%AC%E7%AB%A0%E5%B0%8F%E7%BB%93"><span class="toc-number">2.</span> <span class="toc-text">本章小结</span></a></li></ol></div></div><div class="card-widget card-recent-post"><div class="item-headline"><i class="fas fa-history"></i><span>Recent Posts</span></div><div class="aside-list"><div class="aside-list-item no-cover"><div class="content"><a class="title" href="/2025/08/25/JLPT%E5%A4%87%E6%88%98%E8%AF%AD%E6%B3%95%E5%88%B7%E9%A2%98/" title="JLPT备战语法刷题">JLPT备战语法刷题</a><time datetime="2025-08-24T16:10:25.000Z" title="Created 2025-08-25 00:10:25">2025-08-25</time></div></div><div class="aside-list-item no-cover"><div class="content"><a class="title" href="/2025/08/24/N2%E8%AF%AD%E6%B3%95/" title="N2语法">N2语法</a><time datetime="2025-08-24T05:32:40.000Z" title="Created 2025-08-24 13:32:40">2025-08-24</time></div></div><div class="aside-list-item no-cover"><div class="content"><a class="title" href="/2025/08/20/%E8%B0%B7%E6%AD%8C%E8%99%B9%E5%92%B2%E6%97%A5%E5%8E%86/" title="谷歌虹咲日历">谷歌虹咲日历</a><time datetime="2025-08-20T14:39:38.000Z" title="Created 2025-08-20 22:39:38">2025-08-20</time></div></div><div class="aside-list-item no-cover"><div class="content"><a class="title" href="/2025/06/27/%E7%94%9F%E7%90%86%E5%AD%A6%E5%A4%8D%E4%B9%A0%E9%83%A8%E5%88%86/" title="生理学复习部分">生理学复习部分</a><time datetime="2025-06-27T09:20:36.000Z" title="Created 2025-06-27 17:20:36">2025-06-27</time></div></div><div class="aside-list-item no-cover"><div class="content"><a class="title" href="/2025/06/25/%E7%94%9F%E7%89%A9%E8%8D%AF%E7%89%A9%E5%88%86%E7%A6%BB%E5%B7%A5%E7%A8%8B%E5%A4%8D%E4%B9%A0/" title="生物药物分离工程复习">生物药物分离工程复习</a><time datetime="2025-06-25T11:49:35.000Z" title="Created 2025-06-25 19:49:35">2025-06-25</time></div></div></div></div></div></div></main><footer id="footer"><div id="footer-wrap"><div class="copyright">&copy;2025 By 夜雕</div><div class="framework-info"><span>Framework </span><a target="_blank" rel="noopener" href="https://hexo.io">Hexo 7.3.0</a><span class="footer-separator">|</span><span>Theme </span><a target="_blank" rel="noopener" href="https://github.com/jerryc127/hexo-theme-butterfly">Butterfly 5.3.5</a></div></div></footer></div><div id="rightside"><div id="rightside-config-hide"><button id="readmode" type="button" title="Reading Mode"><i class="fas fa-book-open"></i></button><button id="darkmode" type="button" title="Toggle Between Light and Dark Mode"><i class="fas fa-adjust"></i></button><button id="hide-aside-btn" type="button" title="Toggle Between Single-column and Double-column"><i class="fas fa-arrows-alt-h"></i></button></div><div id="rightside-config-show"><button id="rightside-config" type="button" title="Settings"><i class="fas fa-cog fa-spin"></i></button><button class="close" id="mobile-toc-button" type="button" title="Table of Contents"><i class="fas fa-list-ul"></i></button><a id="to_comment" href="#post-comment" title="Scroll to Comments"><i class="fas fa-comments"></i></a><button id="go-up" type="button" title="Back to Top"><span class="scroll-percent"></span><i class="fas fa-arrow-up"></i></button></div></div><div><script src="/js/utils.js"></script><script src="/js/main.js"></script><div class="js-pjax"><script>(() => {
  const loadMathjax = () => {
    if (!window.MathJax) {
      window.MathJax = {
        tex: {
          inlineMath: [['$', '$'], ['\\(', '\\)']],
          tags: 'none',
        },
        chtml: {
          scale: 1.1
        },
        options: {
          enableMenu: true,
          renderActions: {
            findScript: [10, doc => {
              for (const node of document.querySelectorAll('script[type^="math/tex"]')) {
                const display = !!node.type.match(/; *mode=display/)
                const math = new doc.options.MathItem(node.textContent, doc.inputJax[0], display)
                const text = document.createTextNode('')
                node.parentNode.replaceChild(text, node)
                math.start = {node: text, delim: '', n: 0}
                math.end = {node: text, delim: '', n: 0}
                doc.math.push(math)
              }
            }, '']
          }
        }
      }

      const script = document.createElement('script')
      script.src = 'https://cdn.jsdelivr.net/npm/mathjax/es5/tex-mml-chtml.min.js'
      script.id = 'MathJax-script'
      script.async = true
      document.head.appendChild(script)
    } else {
      MathJax.startup.document.state(0)
      MathJax.texReset()
      MathJax.typesetPromise()
    }
  }

  btf.addGlobalFn('encrypt', loadMathjax, 'mathjax')
  window.pjax ? loadMathjax() : window.addEventListener('load', loadMathjax)
})()</script><script>(() => {
  const runMermaid = ele => {
    window.loadMermaid = true
    const theme = document.documentElement.getAttribute('data-theme') === 'dark' ? 'dark' : 'default'

    ele.forEach((item, index) => {
      const mermaidSrc = item.firstElementChild
      const mermaidThemeConfig = `%%{init:{ 'theme':'${theme}'}}%%\n`
      const mermaidID = `mermaid-${index}`
      const mermaidDefinition = mermaidThemeConfig + mermaidSrc.textContent

      const renderFn = mermaid.render(mermaidID, mermaidDefinition)
      const renderMermaid = svg => {
        mermaidSrc.insertAdjacentHTML('afterend', svg)
      }

      // mermaid v9 and v10 compatibility
      typeof renderFn === 'string' ? renderMermaid(renderFn) : renderFn.then(({ svg }) => renderMermaid(svg))
    })
  }

  const codeToMermaid = () => {
    const codeMermaidEle = document.querySelectorAll('pre > code.mermaid')
    if (codeMermaidEle.length === 0) return

    codeMermaidEle.forEach(ele => {
      const preEle = document.createElement('pre')
      preEle.className = 'mermaid-src'
      preEle.hidden = true
      preEle.textContent = ele.textContent
      const newEle = document.createElement('div')
      newEle.className = 'mermaid-wrap'
      newEle.appendChild(preEle)
      ele.parentNode.replaceWith(newEle)
    })
  }

  const loadMermaid = () => {
    if (true) codeToMermaid()
    const $mermaid = document.querySelectorAll('#article-container .mermaid-wrap')
    if ($mermaid.length === 0) return

    const runMermaidFn = () => runMermaid($mermaid)
    btf.addGlobalFn('themeChange', runMermaidFn, 'mermaid')
    window.loadMermaid ? runMermaidFn() : btf.getScript('https://cdn.jsdelivr.net/npm/mermaid/dist/mermaid.min.js').then(runMermaidFn)
  }

  btf.addGlobalFn('encrypt', loadMermaid, 'mermaid')
  window.pjax ? loadMermaid() : document.addEventListener('DOMContentLoaded', loadMermaid)
})()</script><script>(() => {
  const isShuoshuo = GLOBAL_CONFIG_SITE.pageType === 'shuoshuo'
  const option = null

  const commentCount = n => {
    const isCommentCount = document.querySelector('#post-meta .gitalk-comment-count')
    if (isCommentCount) {
      isCommentCount.textContent= n
    }
  }

  const initGitalk = (el, path) => {
    if (isShuoshuo) {
      window.shuoshuoComment.destroyGitalk = () => {
        if (el.children.length) {
          el.innerHTML = ''
          el.classList.add('no-comment')
        }
      }
    }

    const gitalk = new Gitalk({
      clientID: 'Ov23li781UgrbfNipxDE',
      clientSecret: '81cb418710e58c6bc79ec93cd11ffebf9f61e4c3',
      repo: 'LF12306.github.io',
      owner: 'LF12306',
      admin: ['LF12306'],
      updateCountCallback: commentCount,
      ...option,
      id: isShuoshuo ? path : (option && option.id) || '6c0c2f529bb53a94f68820623b6af5e3'
    })

    gitalk.render('gitalk-container')
  }

  const loadGitalk = async(el, path) => {
    if (typeof Gitalk === 'function') initGitalk(el, path)
    else {
      await btf.getCSS('https://cdn.jsdelivr.net/npm/gitalk/dist/gitalk.min.css')
      await btf.getScript('https://cdn.jsdelivr.net/npm/gitalk/dist/gitalk.min.js')
      initGitalk(el, path)
    }
  }

  if (isShuoshuo) {
    'Gitalk' === 'Gitalk'
      ? window.shuoshuoComment = { loadComment: loadGitalk }
      : window.loadOtherComment = loadGitalk
    return
  }

  if ('Gitalk' === 'Gitalk' || !true) {
    if (true) btf.loadComment(document.getElementById('gitalk-container'), loadGitalk)
    else loadGitalk()
  } else {
    window.loadOtherComment = loadGitalk
  }
})()</script></div><script src="/js/currency.js"></script><script async data-pjax src="//busuanzi.ibruce.info/busuanzi/2.3/busuanzi.pure.mini.js"></script><div id="local-search"><div class="search-dialog"><nav class="search-nav"><span class="search-dialog-title">Search</span><span id="loading-status"></span><button class="search-close-button"><i class="fas fa-times"></i></button></nav><div class="text-center" id="loading-database"><i class="fas fa-spinner fa-pulse"></i><span>  Loading Database</span></div><div class="search-wrap"><div id="local-search-input"><div class="local-search-box"><input class="local-search-box--input" placeholder="要搜点什么呢？" type="text"/></div></div><hr/><div id="local-search-results"></div><div id="local-search-stats-wrap"></div></div></div><div id="search-mask"></div><script src="/js/search/local-search.js"></script></div></div></body></html>